Form 8-K - Current report:
SEC Accession No. 0001558370-25-007665
Filing Date
2025-05-14
Accepted
2025-05-14 08:05:19
Documents
49
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20250514x8k.htm   iXBRL 8-K 41543
2 EX-99.1 apre-20250514xex99d1.htm EX-99.1 123872
3 EX-99.2 apre-20250514xex99d2.htm EX-99.2 53745
4 GRAPHIC apre-20250514xex99d1002.jpg GRAPHIC 8841
5 GRAPHIC apre-20250514xex99d2g001.jpg GRAPHIC 98266
6 GRAPHIC apre-20250514xex99d2g002.jpg GRAPHIC 302070
7 GRAPHIC apre-20250514xex99d2g003.jpg GRAPHIC 175960
8 GRAPHIC apre-20250514xex99d2g004.jpg GRAPHIC 116914
9 GRAPHIC apre-20250514xex99d2g005.jpg GRAPHIC 133754
10 GRAPHIC apre-20250514xex99d2g006.jpg GRAPHIC 170136
11 GRAPHIC apre-20250514xex99d2g007.jpg GRAPHIC 56471
12 GRAPHIC apre-20250514xex99d2g008.jpg GRAPHIC 189355
13 GRAPHIC apre-20250514xex99d2g009.jpg GRAPHIC 82176
14 GRAPHIC apre-20250514xex99d2g010.jpg GRAPHIC 157141
15 GRAPHIC apre-20250514xex99d2g011.jpg GRAPHIC 108084
16 GRAPHIC apre-20250514xex99d2g012.jpg GRAPHIC 57402
17 GRAPHIC apre-20250514xex99d2g013.jpg GRAPHIC 74019
18 GRAPHIC apre-20250514xex99d2g014.jpg GRAPHIC 144565
19 GRAPHIC apre-20250514xex99d2g015.jpg GRAPHIC 213728
20 GRAPHIC apre-20250514xex99d2g016.jpg GRAPHIC 153546
21 GRAPHIC apre-20250514xex99d2g017.jpg GRAPHIC 131527
22 GRAPHIC apre-20250514xex99d2g018.jpg GRAPHIC 131673
23 GRAPHIC apre-20250514xex99d2g019.jpg GRAPHIC 147318
24 GRAPHIC apre-20250514xex99d2g020.jpg GRAPHIC 53828
25 GRAPHIC apre-20250514xex99d2g021.jpg GRAPHIC 167319
26 GRAPHIC apre-20250514xex99d2g022.jpg GRAPHIC 112988
27 GRAPHIC apre-20250514xex99d2g023.jpg GRAPHIC 152537
28 GRAPHIC apre-20250514xex99d2g024.jpg GRAPHIC 108011
29 GRAPHIC apre-20250514xex99d2g025.jpg GRAPHIC 58334
30 GRAPHIC apre-20250514xex99d2g026.jpg GRAPHIC 130717
31 GRAPHIC apre-20250514xex99d2g027.jpg GRAPHIC 195077
32 GRAPHIC apre-20250514xex99d2g028.jpg GRAPHIC 150310
33 GRAPHIC apre-20250514xex99d2g029.jpg GRAPHIC 78365
34 GRAPHIC apre-20250514xex99d2g030.jpg GRAPHIC 162825
35 GRAPHIC apre-20250514xex99d2g031.jpg GRAPHIC 193024
36 GRAPHIC apre-20250514xex99d2g032.jpg GRAPHIC 150519
  Complete submission text file 0001558370-25-007665.txt   6333113

Data Files

Seq Description Document Type Size
37 EX-101.SCH apre-20250514.xsd EX-101.SCH 4090
38 EX-101.DEF apre-20250514_def.xml EX-101.DEF 2845
39 EX-101.LAB apre-20250514_lab.xml EX-101.LAB 16594
40 EX-101.PRE apre-20250514_pre.xml EX-101.PRE 10904
51 EXTRACTED XBRL INSTANCE DOCUMENT apre-20250514x8k_htm.xml XML 4677
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 25942716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)